当前位置: 首页 > 期刊 > 《全科医学临床与教育》 > 2006年第2期
编号:11026838
尿激酶减量溶栓治疗高龄急性心肌梗死患者的临床研究
http://www.100md.com 《全科医学临床与教育》 2006年第2期
尿激酶;急性心肌梗死;高龄患者;溶栓,,]尿激酶;急性心肌梗死;高龄患者;溶栓,1对象与方法,2结果,3讨论,参考文献
     [摘要]目的探讨尿激酶治疗高龄急性心肌梗死(AMI)患者(年龄≥70岁)的剂量、疗效及安全性。方法高龄组28例(年龄≥70岁)使用减量尿激酶(UK)溶栓治疗,对照组30例(年龄<70岁)使用常规剂量尿激酶(UK)溶栓治疗,分别观察溶栓治疗的疗效和主要不良反应。结果高龄组与对照组溶栓治疗的疗效及主要不良反应比较无显著差异(P>0.05)。结论高龄急性心肌梗死患者(年龄≥70岁)使用减量尿激酶(UK)溶栓治疗,疗效可靠且较安全。

    [关键词]尿激酶;急性心肌梗死;高龄患者;溶栓

    The effect of thrombolytic therapy with decreasing doses of urokinase in elderly patients with acute myocardial infarction CHEN Fayu,LV Tan.Department of cardiovascular,Zhejiang University Medical School,Hangzhou,310031,China

    [Abstract] Objective To investigate the doses,efficacy and safety of thrombolytic therapy with urokinase in elderly patients(age≥70years)with acute myocardial infarction.Methods The elderly group included28patients were treated with thrombolytic therapy with decreasing doses of urokinase,and the control group included30patients were treated with thrombolytic therapy with routine doses.The efficacy and the major side effects were observed between two groups.Results The efficacy and the major side effects of thrombolytic therapy with urokinase had no significant dif-ference between two groups.(P>0.05)Conclusions Thrombolytic therapy with decreasing doses of urokinase is safe and reliable to elderly patients(age≥70years)with acute myocardial infarction. ......

您现在查看是摘要页,全文长 7712 字符